$108 Million is the total value of Polaris Venture Management Co IV LLC's 3 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2014 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-10-23
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Acceleron Pharma Inc | 12 | Q3 2016 | 85.9% |
| Alimera Sciences Inc | 12 | Q3 2016 | 16.4% |
| Cerulean Pharma Inc | 10 | Q3 2016 | 10.8% |
| Pulmatrix Inc | 6 | Q3 2016 | 15.9% |
| TechTarget Inc | 2 | Q1 2014 | 8.1% |
View Polaris Venture Management Co IV LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2020-05-06 |
| 3 | 2020-04-30 |
| 4 | 2018-04-05 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2017-02-14 |
| 13F-HR | 2016-05-13 |
| 13F-HR | 2016-02-16 |
| 13F-HR | 2015-11-10 |
| 13F-HR | 2015-08-11 |
| 4/A | 2015-06-25 |
View Polaris Venture Management Co IV LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.